Insight Guru says CrowdStrike’s 33.8% five-year annual return trails S&P 500 on return per volatility point
Bitget2026/09/30 16:31- Insight Guru analysis flagged CrowdStrike’s higher returns as partly offset by outsized volatility versus the S&P 500.
- Five-year annualized return of 33.8% exceeded the index’s 13.9%; annual volatility ran 52.6% versus 17.0%.
- Return-to-volatility ratio was 0.64 for CrowdStrike versus 0.81 for the index, implying weaker risk-adjusted performance.
- Past year showed average up-day gain of 1.17% versus 0.63% for the index; average down-day loss was 0.57% versus 0.61%.
- Fiscal Q2 2027 revenue rose 26% to $1.47 billion; operating margin stayed negative at -2.2%, supporting expectations of continued swings.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ido Ben-Natan: Frequent on-chain security incidents, AI agents will increase risks
BTC rebounds and breaks through 83,000 USDT, with a 24-hour decrease of 1%
Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Crypto prices
More
